Asian Hematology Research Journal 2021-08-04T13:50:14+00:00 Asian Hematology Research Journal Open Journal Systems <p style="text-align: justify;"><strong>Asian Hematology Research Journal</strong>&nbsp;aims to publish&nbsp;high-quality&nbsp;papers (<a href="/index.php/AHRJ/general-guideline-for-authors">Click here for Types of paper</a>) in all areas of&nbsp;‘Hematology research’. This journal facilitates the research and wishes to publish papers as long as they are technically correct, scientifically motivated. The journal also encourages the submission of useful reports of negative results. This is a quality controlled,&nbsp;OPEN&nbsp;peer-reviewed, open access INTERNATIONAL journal.</p> Uncommon Presentation of Hodgkin’s Lymphoma: A Case Report 2021-07-27T09:29:16+00:00 C. E. Nonyelu A. J. Madu I. O. Anigbogu O. C. Okafor <p>Hodgkin’s lymphoma is a lymphoid malignancy that rarely presents with extranodal involvement and even rarer is presentation involving the central nervous system (CNS). The index patient had a diagnosis of Hodgkin’s lymphoma made from histology and immunophenotyping of the cervical lymph node biopsy. However, involvement of the thoracic vertebrae and epidural with attendant neurological manifestations occurred while on treatment. The central nervous system (CNS) involvement was not biopsied but an impression of Hodgkin’s lymphoma with CNS involvement was made based on primary tissue diagnosis and patient treated as such. He passed on subsequently following complications of chemotherapy and radiotherapy.</p> 2021-07-27T09:28:23+00:00 ##submission.copyrightStatement## Coexistence of Pyoderma Gangrenosum and Acute Lymphoblastic Leukemia 2021-08-04T09:17:51+00:00 Gamal Abdul Hamid Amani Hussein <p><strong>Background:</strong> Pyoderma gangrenosum (PG) is a rare skin disease has been reported in association with acute myeloid leukemia, myeloproliferative disorders, myeloid metaplasia and myeloma is well known, but their association with lymphoid malignant tumors, is extremely rare. (PG) is a serious ulcerating skin disease characterized by the presence of the necrotic ulcer of the skin accompanied by pain.</p> <p><strong>Case Presentation:</strong> We report a rare case of a 25-year- male presented with recurrent fever and general weakness and episodes of typical skin lesion of bullous pyoderma gangrenosum since two months and now associated with pallor and bleeding tendency<strong>.</strong></p> <p><strong>Conclusion: </strong>Complete remission of blood and bone marrow findings after first induction chemotherapy associated with early regression of all other manifestations.</p> 2021-08-04T00:00:00+00:00 ##submission.copyrightStatement## Hepatitis B Virus Awareness and Vaccine Coverage among Voluntary Blood Donors in Jos: Implication for Eradicating the Hepatitis B Virus 2021-08-04T13:50:14+00:00 Ayuba Zakari Ezra Danjuma Jatau Victoria Ma’an Tapsuk Michael A. Onoja Dahal Abdenego Samuel Lami Bako <p>Hepatitis B virus (HBV) is one of the leading causes of chronic viral infections worldwide. The World Health Organization (WHO) aims to eliminate HBV as a global health threat by 2030. Our study, therefore, aimed to identify factors that may hinder the WHO’s objective of eradicating HBV in our environment and suggests ways of addressing them.</p> <p>We conducted a survey at the National Blood Transfusion Service, Jos, among voluntary non remunerated blood donors (VNRBD) aged 18-65 years from October to December 2020 using structured questionnaires addressing awareness of HBV, vaccine uptake, socio-demography, and other information. Of the 120 participants, 88.3% were aware of HBV. The majority (35.8%) had heard about the virus through Health talks given at schools and hospitals by health personnel, followed by Social media (25.5%), Family members (18.0%), Friends (13.2%), Taught in School (2.8%), Mass media (1.9%), Print media (1.9%) and told by a patient (0.9%). A Significant proportion of the population (63.6%) was found to be unvaccinated against HBV, citing unawareness of the vaccine (57.9%) and not knowing where to get the vaccine (21.6%) as reasons for non-uptake. The participants’ sources of awareness of HBV vaccine were Health talk (40.9%), Social media (18.2%), Friends (15.2%), Family members (10.6%), taught in school (4.5%), Mass media (4.5%), Print media (4.5%), and told by a patient (1.5%). This study found that awareness of HBV among participants did not translate into increased vaccine uptake. We identified unawareness, poor accessibility and unavailability of the vaccine as obstacles for eradicating HBV in our setting. We recommend strengthening childhood immunization, teaching about vaccines at elementary schools, increasing social media utilization for vaccine information dissemination, and increased availability of the vaccine.</p> 2021-08-04T00:00:00+00:00 ##submission.copyrightStatement##